Finally, we implanted the cells described above into mouse brains and found that tumor volume and weight were significantly decreased for Sox2-ko cells treated with the same TMZ dose (2 mg/kg), and survival time was prolonged significantly (Fig 5E-F). This evidence concerns the gene SOX2 and neoplasm.